Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial update of erlotinib and sorafenib in progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma [Phase 1]
Phase 1 trial evaluating temozolomide with radiation therapy for newly diagnosed glioblastoma and anaplastic astrocytoma; results have been …
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma [Phase 1]
A Phase 1 pilot study tested the safety of bone marrow-derived stem cells in patients with glioblastoma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma [Phase 1, Phase 2]
A completed Phase I/II clinical trial evaluating IMA950 multi-peptide vaccine plus Poly-ICLC in adults with glioblastoma.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma [Phase 1]
Phase 1 clinical trial update of dovitinib (TKI258) in patients with relapsed glioblastoma (first or second recurrence).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and pos…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas [Phase 2]
Results from a Phase II randomized trial in adults with recurrent high-grade gliomas comparing vandetanib with carboplatin followed by vande…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors [Phase 2]
Phase 2 study evaluating aminolevulinic acid to enhance visualization and surgical removal of brain tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Post-approval Study of NovoTTF-100A in Recurrent GBM Patients [Phase 4]
A post-approval Phase 4 study of NovoTTF-100A in patients with recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sunitinib in Treating Patients With Recurrent Malignant Gliomas [Phase 2]
Phase 2 trial evaluating sunitinib for adults with recurrent malignant gliomas has completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma [Phase 2]
This Phase 2 clinical trial update reports results for temozolomide in patients with recurrent glioblastoma multiforme or other malignant gl…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 3]
A Phase 3 clinical trial evaluating conventional adjuvant temozolomide with dose-intensive temozolomide in newly diagnosed Glioblastoma has …
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
ClinicalTrials.gov indicates a completed Phase 1/2 study evaluating cilengitide with temozolomide and radiation for newly diagnosed glioblas…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating magnetic resonance spectroscopic imaging and tumor perfusion i…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating suppression of the PI3K/Akt pathway in glioblastoma and gliosarcoma, compared with pembrolizumab (MK-347…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
This update reports results from a completed clinical trial comparing different methods to test MGMT status in glioblastoma patients.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial assessed the combination of everolimus with gefitinib in patients with progressive glioblastoma and progressive metastatic…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: AMG 102 and Avastin for Recurrent Malignant Glioma [Phase 2]
Phase 2 trial results for AMG 102 in combination with Avastin (bevacizumab) for recurrent malignant glioma have been posted. The study inclu…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Memantine for Recurrent Glioblastoma [Phase 2]
A Phase 2 trial of memantine for recurrent glioblastoma was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients [Phase 3]
A Phase 3 trial assessed duloxetine for mood, quality of life, and cognitive functioning in glioblastoma patients; the study has been termin…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma [Phase 2]
Phase 2 clinical trial comparing Avastin (bevacizumab) with irinotecan versus temozolomide-based radiochemotherapy in patients with glioblas…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study evaluating computer-planned radiation therapy combined with chemotherapy for gliobla…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Preoperative Chemoradiation for Glioblastoma [Phase 1]
Phase 1 results from a preoperative chemoradiation trial for glioblastoma have completed. The update summarizes the study's safety and feasi…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients [Phase 2]
Phase II trial evaluating vorinostat (SAHA) in combination with bevacizumab for recurrent malignant glioma, including glioblastoma. The stud…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma [Phase 1, Phase 2]
The completed Phase 1/2 clinical trial evaluated a dendritic cell–based therapy targeting tumor stem cells in glioblastoma, focusing on safe…